Valuation: Ipsen

Market Cap 13.4B 15.64B 12.53B 11.47B 21.58B 1,497B 21.82B 148B 57.69B 752B 58.73B 57.45B 2,486B P/E 2026 *
13.6x
P/E 2027 * 13.9x
Enterprise Value 12.16B 14.2B 11.38B 10.41B 19.58B 1,359B 19.81B 134B 52.36B 682B 53.3B 52.14B 2,256B EV / Sales 2026 *
2.68x
EV / Sales 2027 * 2.39x
Free-Float
40.65%
Yield 2026 *
0.94%
Yield 2027 * 0.94%
1 week+4.74%
Current month-2.27%
1 month+0.68%
3 months+2.00%
6 months+3.61%
Current year+37.31%
1 week 157.4
Extreme 157.4
167.4
1 month 153.1
Extreme 153.1
174
Current year 116
Extreme 116
174
1 year 109.9
Extreme 109.9
174
3 years 87.95
Extreme 87.95
174
5 years 77
Extreme 77
174
10 years 34.2
Extreme 34.2
174
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
8/7/26 A Sell

Chief Executive Officer

-14,300 0.0171%
8/6/26 A Sell

Chief Executive Officer

-8,900 0.0106%
7/31/26 A Fiscal year

Chief Executive Officer

-5,000 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.74%+40.02%+39.90% 15.64B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.16%+4.95%+32.34%+52.09% 381.55B
Weighted average by Cap. +1.13%+5.09%+44.24%+72.51%

Financials

2026 *2027 *
Net sales 4.54B 5.31B 4.25B 3.89B 7.32B 508B 7.4B 50.25B 19.57B 255B 19.92B 19.48B 843B 4.64B 5.41B 4.34B 3.97B 7.47B 518B 7.55B 51.28B 19.97B 260B 20.33B 19.88B 860B
Net income 1.01B 1.18B 946M 865M 1.63B 113B 1.65B 11.18B 4.35B 56.72B 4.43B 4.33B 188B 985M 1.15B 922M 843M 1.59B 110B 1.61B 10.9B 4.24B 55.3B 4.32B 4.23B 183B
Net Debt -1.24B -1.45B -1.16B -1.06B -1.99B -138B -2.02B -13.69B -5.33B -69.47B -5.43B -5.31B -230B -2.3B -2.69B -2.15B -1.97B -3.7B -257B -3.75B -25.43B -9.9B -129B -10.08B -9.86B -427B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
21/08/26 €163.40 0.00% 53,626
20/08/26 €163.40 -1.03% 94,571
19/08/26 €165.10 +0.86% 72,813
18/08/26 €163.70 +1.36% 84,590
17/08/26 €161.50 +3.53% 81,464
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
163.40EUR
Average target price
167.07EUR
Spread / Average Target
+2.24%

Quarterly revenue - Rate of surprise